Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med. 2007;356:2457–71. https://doi.org/10.1056/NEJMoa072761.

Article  CAS  PubMed  Google Scholar 

Singh S, Loke YK, Furberg CD. Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA. 2007;298:1189–95. https://doi.org/10.1001/jama.298.10.1189.

Article  CAS  PubMed  Google Scholar 

Fujita T. Signal detection of adverse drug reactions. Jpn J Pharmacoepidemiol. 2009;14:27–36. https://doi.org/10.3820/jjpe.14.27.

Article  Google Scholar 

Noguchi Y, Takaoka M, Hayashi T, Tachi T, Teramachi H. Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of a Japanese pharmacovigilance database. Epilepsia. 2020;61:1979–89. https://doi.org/10.1111/epi.16626.

Article  CAS  PubMed  Google Scholar 

Gastaldon C, Schoretsanitis G, Arzenton E, Raschi E, Papola D, Ostuzzi G, Moretti U, Seifritz E, Kane JM, Trifirò G, Barbui C. Withdrawal syndrome following discontinuation of 28 antidepressants: pharmacovigilance analysis of 31,688 reports from the WHO Spontaneous Reporting Database. Drug Saf. 2022;45:1539–49. https://doi.org/10.1007/s40264-022-01246-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xia S, Gong H, Zhao Y, Guo L, Wang Y, Ma R, Zhang B, Sarangdhar M, Noguchi Y, Yan M. Tumor lysis syndrome associated with monoclonal antibodies in patients with multiple myeloma: a pharmacovigilance study based on the FAERS database. Clin Pharmacol Ther. 2023. https://doi.org/10.1002/cpt.2920.

Article  PubMed  Google Scholar 

Noguchi Y, Tachi T, Teramachi H. Detection algorithms and attentive points of safety signal using spontaneous reporting systems as a clinical data source. Brief Bioinform. 2021;22:bbab347. https://doi.org/10.1093/bib/bbab347.

Article  PubMed  Google Scholar 

Watanabe H, Matsushita Y, Watanabe A, Maeda T, Nukui K, Ogawa Y, Sawa J, Maeda H. Early detection of important safety information. Jpn J Biomet. 2004;25:37–60. https://doi.org/10.5691/jjb.25.37.

Article  Google Scholar 

Bate A, Evans SJ. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf. 2009;18:427–36. https://doi.org/10.1002/pds.1742.

Article  CAS  PubMed  Google Scholar 

Huang L, Guo T, Zalkikar JN, Tiwari RC. A review of statistical methods for safety surveillance. Ther Innov Regul Sci. 2014;48:98–108. https://doi.org/10.1177/2168479013514236.

Article  PubMed  Google Scholar 

Vilar S, Friedman C, Hripcsak G. Detection of drug–drug interactions through data mining studies using clinical sources, scientific literature and social media. Brief Bioinform. 2018;19:863–77. https://doi.org/10.1093/bib/bbx010.

Article  CAS  PubMed  Google Scholar 

Noguchi Y, Tachi T, Teramachi H. Review of statistical methodologies for detecting drug–drug interactions using spontaneous reporting systems. Front Pharmacol. 2019;10:1319. https://doi.org/10.3389/fphar.2019.01319.

Article  PubMed  PubMed Central  Google Scholar 

Soldin OP, Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2009;48:143–57. https://doi.org/10.2165/00003088-200948030-00001.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Forger NG. Epigenetic mechanisms in sexual differentiation of the brain and behaviour. Philos Trans R Soc Lond B Biol Sci. 2016;371:20150114. https://doi.org/10.1098/rstb.2015.0114.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cohen S, Murphy MLM, Prather AA. Ten surprising facts about stressful life events and disease risk. Annu Rev Psychol. 2019;70:577–97. https://doi.org/10.1146/annurev-psych-010418-102857.

Article  PubMed  Google Scholar 

Noguchi Y, Hayashi Y, Yoshida A, Sugita I, Esaki H, Saito K, Usui K, Kato M, Tachi T, Teramachi H. Search for oral medicine that might exacerbate the prognosis of adverse drug events in elderly patients. Jpn J Drug Inf. 2016;18:277–83. https://doi.org/10.11256/jjdi.18.277.

Article  Google Scholar 

van Puijenbroek EP, Bate A, Leufkens HGM, Lindquist M, Orre R, Egberts ACG. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002;11:3–10. https://doi.org/10.1002/pds.668.

Article  CAS  PubMed  Google Scholar 

https://www.ema.europa.eu/en/documents/other/screening-adverse-reactions-eudravigilance_en.pdf. Accessed June 25, 2023.

Omoto T, Asaka J, Sakai T, Sato F, Goto N, Kudo K. Disproportionality analysis of safety signals for a wide variety of opioid-related adverse events in elderly patients using the Japanese Adverse Drug Event Report (JADER) Database. Biol Pharm Bull. 2021;44:627–34.

Article  CAS  PubMed  Google Scholar 

Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A, De Freitas RM. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol. 1998;54:315–21. https://doi.org/10.1007/s002280050466.

Article  CAS  PubMed  Google Scholar 

Lindquist M, Stahl M, Bate A, Edwards IR, Meyboom RHB. A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database. Drug Saf. 2000;23:533–42. https://doi.org/10.2165/00002018-200023060-00004.

Article  CAS  PubMed  Google Scholar 

Yang K, Li J, Sun Z, Bai C, Zhao L. Effect of age on the risk of immune-related adverse events in patients receiving immune checkpoint inhibitors. Clin Exp Med. 2023. https://doi.org/10.1007/s10238-023-01055-8.

Article  PubMed  PubMed Central  Google Scholar 

Sandberg L, Taavola H, Aoki Y, Chandler R, Norén GN. Risk factor considerations in statistical signal detection: using subgroup disproportionality to uncover risk groups for adverse drug reactions in VigiBase. Drug Saf. 2020;43:999–1009. https://doi.org/10.1007/s40264-020-00957-w.

Article  PubMed  PubMed Central  Google Scholar 

Wakao R, Lönnstedt IM, Aoki Y, Chandler RE. The use of subgroup disproportionality analyses to explore the sensitivity of a global database of individual case safety reports to known pharmacogenomic risk variants common in Japan. Drug Saf. 2021;44:681–97. https://doi.org/10.1007/s40264-021-01063-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu Y, Chen J, Li D, Wang L, Wang W, Liu H. Systematic analysis of adverse event reports for sex differences in adverse drug events. Sci Rep. 2016;22(6):24955. https://doi.org/10.1038/srep24955.

Article  ADS  CAS  Google Scholar 

Kan Y, Nagai J, Uesawa Y. Evaluation of antibiotic-induced taste and smell disorders using the FDA adverse event reporting system database. Sci Rep. 2021;11:9625. https://doi.org/10.1038/s41598-021-88958-2.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Toyoshima M, Noguchi Y, Otsubo M, Tachi T, Teramachi H. Differences in detected safety signals between benzodiazepines and non-benzodiazepine hypnotics: pharmacovigilance study using a spontaneous reporting system. Int J Med Sci. 2021;18:1130–6. https://doi.org/10.7150/ijms.51658.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nagaoka K, Nagashima T, Asaoka N, Yamamoto H, Toda C, Kayanuma G, Siswanto S, Funahashi Y, Kuroda K, Kaibuchi K, Mori Y, Nagayasu K, Shirakawa H, Kaneko S. Striatal TRPV1 activation by acetaminophen ameliorates dopamine D2 receptor antagonist-induced orofacial dyskinesia. JCI Insight. 2021;6: e145632. https://doi.org/10.1172/jci.insight.145632.

Article  PubMed  PubMed Central  Google Scholar 

Mitsuboshi S, Hamano H, Niimura T, Ozaki AF, Patel PM, Lin TJ, Tanaka Y, Kimura I, Iwata N, Shiromizu S, Chuma M, Koyama T, Yamanishi Y, Kanda Y, Ishizawa K, Zamami Y. Association between immune checkpoint inhibitor-induced myocarditis and concomitant use of thiazide diuretics. Int J Cancer. 2023. https://doi.org/10.1002/ijc.34616.

Article  PubMed  Google Scholar 

Jin W, Riley RM, Wolfinger RD, White KP, Passador-Gurgel G, Gibson G. The contributions of sex, genotype and age to transcriptional variance in Drosophila melanogaster. Nat Genet. 2001;29:389–95. https://doi.org/10.1038/ng766.

Article  CAS  PubMed  Google Scholar 

Cui X, Churchill GA. Statistical tests for differential expression in cDNA microarray experiments. Genome Biol. 2003;4:210. https://doi.org/10.1186/gb-2003-4-4-210.

Article  PubMed  PubMed Central  Google Scholar 

Ebrahimpoor M, Goeman JJ. Inflated false discovery rate due to volcano plots: problem and solutions. Brief Bioinform. 2021;22:bbab053. https://doi.org/10.1093/bib/bbab053.

Article  PubMed  PubMed Central  Google Scholar 

Matsuda S. Introduction of FDR and comparisons of multiple testing procedures that control it. Jpn J Biometr. 2008;29:125–39. https://doi.org/10.5691/jjb.29.125.

Article  Google Scholar 

Pham P, Cheng C, Wu E, Kim I, Zhang R, Ma Y, Kortepeter CM, Muñoz MA. Leveraging case narratives to enhance patient age ascertainment from adverse event reports. Pharmaceut Med. 2021;35:307–16. https://doi.org/10.1007/s40290-021-00398-5.

Article  PubMed  PubMed Central